Instrument Inactif

Communiqués Cancer Genetics, Inc.

Actions

CGIX

US13739U2033

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Cancer Genetics : Vyant Bio Presentation – April 2021	06/04/21	PU
Cancer Genetics and StemoniX Announce Merger Closing	31/03/21	GL
CANCER GENETICS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	31/03/21	AQ
CANCER GENETICS, INC : Submission of Matters to a Vote of Security Holders, Other Events (form 8-K)	25/03/21	AQ
Cancer Genetics Announces Shareholder Approval of All Proposals in Connection with the Proposed Merger with StemoniX	25/03/21	GL
Cancer Genetics : Announces Roland J. Carrillo, PhD as Vice President of Business Development	18/03/21	AQ
CANCER GENETICS, INC : Other Events (form 8-K)	16/03/21	AQ
Cancer Genetics to Present at the Annual 33rd ROTH Conference	12/03/21	GL
Cancer Genetics : Company Presentation Q1 2021	05/03/21	PU
Cancer Genetics to Present at the H.C. Wainwright Global Life Sciences Conference	04/03/21	GL
CANCER GENETICS, INC : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	26/02/21	AQ
CANCER GENETICS, INC : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Other Events, Financial Statements and Exhibits (form 8-K)	16/02/21	AQ
Cancer Genetics Announces Closing of $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq Rules	16/02/21	GL
Cancer Genetics Announces $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq Rules	11/02/21	GL
CANCER GENETICS, INC : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	08/02/21	AQ
CANCER GENETICS, INC : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Other Events, Financial Statements and Exhibits (form 8-K)	01/02/21	AQ
Cancer Genetics Announces Closing of $10.0 Million Private Placement Priced At-the-Market	01/02/21	GL
Cancer Genetics Announces $10.0 Million Private Placement Priced At-the-Market	28/01/21	GL
CANCER GENETICS, INC : Other Events (form 8-K)	28/01/21	AQ
Cancer Genetics : Company Presentation Q1 2021	08/01/21	PU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Cancer Genetics, Inc.

Actions

CGIX

US13739U2033

Communiqués

Filtres